Loading...
Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment
Chagas' disease, a neglected tropical illness for which current therapy is unsatisfactory, is caused by the intracellular parasite Trypanosoma cruzi. The goal of this work is to investigate the in vitro and in vivo effects of the arylimidamide (AIA) DB766 against T. cruzi. This arylimidamide ex...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2897275/ https://ncbi.nlm.nih.gov/pubmed/20457822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01617-09 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|